Canada’s rare disease strategy is working. Now it’s time for Phase 2!
With agreements expiring in March 2027, CORD urges governments to renew $500M in annual federal funding to improve treatment access and care.
🔗 Read CORD’s open letter:raredisorders.ca/uploads/Docume…
#Canada4Rare
With agreements expiring in March 2027, CORD urges governments to renew $500M in annual federal funding to improve treatment access and care.
🔗 Read CORD’s open letter:raredisorders.ca/uploads/Docume…
#Canada4Rare